KWALITY PHARMACEUTICALS
Back to Income Statement
|
KWALITY PHARMACEUTICALS Last 5 Year Revenue History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Sales | ₹307 Cr | ₹251 Cr | ₹456 Cr | ₹262 Cr | ₹139 Cr |
What is the latest Revenue of KWALITY PHARMACEUTICALS ?
| Year | Revenue |
|---|---|
| Mar2025 | ₹307 Cr |
| Mar2024 | ₹251 Cr |
| Mar2023 | ₹456 Cr |
| Mar2022 | ₹262 Cr |
| Mar2021 | ₹139 Cr |
How is Revenue of KWALITY PHARMACEUTICALS Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2025 | ₹307 Cr | 22.36 | |
| Mar2024 | ₹251 Cr | -44.97 | |
| Mar2023 | ₹456 Cr | 74.11 | |
| Mar2022 | ₹262 Cr | 88.10 | |
| Mar2021 | ₹139 Cr | - | |
Compare Revenue of peers of KWALITY PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| KWALITY PHARMACEUTICALS | ₹1,067.5 Cr | 8.7% | 7.5% | 16.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹418,708.0 Cr | -2.9% | -1.8% | -2.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹171,975.0 Cr | 2.1% | 0.2% | 9.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹128,619.0 Cr | 0.5% | 2.2% | 11.2% | Stock Analytics | |
| CIPLA | ₹122,539.0 Cr | 0.7% | -0.8% | 3.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,741.0 Cr | -0.1% | 2.5% | 2.5% | Stock Analytics | |
KWALITY PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| KWALITY PHARMACEUTICALS | 8.7% |
7.5% |
16.3% |
| SENSEX | -0.4% |
-0.3% |
3.9% |
You may also like the below Video Courses